Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States over the next five years, creating 12,000 jobs. The Basel-based company, whose array of products includes cancer medicines and multiple sclerosis treatment Ocrevus, said the investment would go toward high-tech research and development sites and new manufacturing facilities in places including California, Indiana, Massachusetts and Pennsylvania. MORE: https://www.wthr.com/article/money/business/swiss-pharmaceuticals-company-roche-announces-50b-investment-in-us-over-next-5-years-picks-indiana-for-new-plant-money-business/531-8b08e30e-a67f-4712-b3f8-857b4db16ce6